CSIS-在全球艾滋病毒下一阶段之前，美国继续领导的挑战（英文）-2020.6-11页_2mb

Summary of "Challenges to Continued U.S. Leadership Ahead of Global HIV's Next Phase"

Core Content

This document outlines the challenges and opportunities facing the U.S. government in maintaining its leadership role in the global HIV response, particularly as the world approaches the end of the first phase of the UNAIDS Fast Track goals. It emphasizes the importance of sustained funding, political commitment, and innovative approaches to address the ongoing HIV epidemic, especially in light of the global impact of the Covid-19 pandemic.

Main Challenges

• Waning Political and Financial Leadership: Domestic and global support for HIV funding has declined, with concerns about the long-term sustainability of programs reliant on PEPFAR and the Global Fund.
• Persistent New Infections: Despite a 40% reduction in the infection rate since the late 1990s, new infections remain high, particularly among vulnerable groups such as adolescent girls and young women (AGYW), members of the LGBTI community, sex workers, and people who inject drugs.
• Treatment and Viral Suppression Gaps: While progress has been made toward the 90-90-90 targets, the global rate is still off track, with only 53% of PLHIV virally suppressed in 2018. Men and young adults are disproportionately affected.
• Comorbidities and Syndemics: HIV often coexists with other diseases and social challenges, such as tuberculosis, non-communicable diseases (NCDs), and mental health issues. These complicate treatment and care, yet are not fully addressed by current HIV programs.
• Limited Country Capacity: Many high-burden countries lack the resources and systems to fully manage their HIV responses, though some are taking greater ownership of their programs.

Main Opportunities

• U.S. Leadership in Global Health: The U.S. remains a key player in the global HIV response through PEPFAR and the Global Fund, which have significantly contributed to reducing new infections and expanding treatment access.
• Leveraging the Pandemic: The response to Covid-19 has highlighted the interconnectedness of global health and the need for strong preparedness. There is potential to use this moment to renew U.S. investment in global health.
• Oral PrEP as a Prevention Tool: Oral pre-exposure prophylaxis (PrEP) offers a promising method for individual-level HIV prevention, but its scale and coverage remain limited, especially in high-burden countries.
• Integration with Universal Health Coverage (UHC): The push for UHC presents an opportunity to integrate HIV services with broader health systems, improving efficiency and access.

Key Recommendations for U.S. Leadership

• Sustain and Expand Funding: The U.S. should maintain and increase its investment in HIV programs to protect progress and ensure continued global impact.
• Protect Funding Commitments: Despite pressures to shift resources to the pandemic response, the U.S. must explicitly protect its HIV funding to avoid setbacks.
• Review and Adapt PEPFAR Strategy: A strategic review of PEPFAR should assess funding allocation and ensure it aligns with current HIV epidemiology and demographics, including the impact of Covid-19.
• Support the Global Fund's Evolution: The U.S. should help shape the Global Fund's future role, whether it continues as a focused HIV instrument or expands to address broader health systems and UHC.
• Strengthen Human Rights Focus: The U.S. must continue to prioritize human rights, particularly in protecting key populations and ensuring equitable access to services.

Impact of the Pandemic

• Disruption of HIV Services: The pandemic has caused service and supply chain disruptions, threatening years of progress in HIV, TB, and malaria control.
• Health System Fragility: The global health system has shown vulnerabilities, especially in developing countries, where HIV services are at risk of being deprioritized.
• Interconnected Health Challenges: The pandemic has demonstrated the interconnectedness of global health, reinforcing the need for robust preparedness and response mechanisms.

Conclusion

The U.S. has a critical role in the next phase of the global HIV response. Its leadership, both financially and politically, is essential to overcoming the challenges posed by the pandemic, sustaining progress, and ensuring that the Fast Track goals are met. A renewed commitment to global health, inclusive of UHC and human rights, will be necessary to address the complex and evolving nature of the HIV epidemic.